Ultragenyx Pharma (RARE) PT Lowered to $47 at Wedbush
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $14.41 -0.62%
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 53
Join SI Premium – FREE
Wedbush analyst Laura Chico lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $47.00 (from $48.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Vertex (VRTX) PT Raised to $615 at UBS
- Akamai Technologies (AKAM) PT Lowered to $150 at DA Davidson
- H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
